NL6702002A - - Google Patents

Info

Publication number
NL6702002A
NL6702002A NL6702002A NL6702002A NL6702002A NL 6702002 A NL6702002 A NL 6702002A NL 6702002 A NL6702002 A NL 6702002A NL 6702002 A NL6702002 A NL 6702002A NL 6702002 A NL6702002 A NL 6702002A
Authority
NL
Netherlands
Application number
NL6702002A
Other versions
NL156921B (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6702002A publication Critical patent/NL6702002A/xx
Publication of NL156921B publication Critical patent/NL156921B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL6702002A 1966-03-08 1967-02-09 PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS. NL156921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE303166A SE319577B (en) 1966-03-08 1966-03-08

Publications (2)

Publication Number Publication Date
NL6702002A true NL6702002A (en) 1967-09-11
NL156921B NL156921B (en) 1978-06-15

Family

ID=20261249

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6702002A NL156921B (en) 1966-03-08 1967-02-09 PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION CONTAINING AS THE ACTIVE INGREDIENT 4-METHYL-5- (2'-CHLORETHYL) -THIA SOLE AND FORMED THERAPEUTIC PREPARED UNDER THIS PROCESS.

Country Status (6)

Country Link
AT (1) AT266126B (en)
BE (1) BE693977A (en)
DE (1) DE1617286B1 (en)
GB (1) GB1147731A (en)
NL (1) NL156921B (en)
SE (1) SE319577B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (en) * 1978-04-25 1980-09-10 Plc Pharma Licences STABILIZATION PROCEDURE

Also Published As

Publication number Publication date
NL156921B (en) 1978-06-15
BE693977A (en) 1967-08-14
SE319577B (en) 1970-01-19
DE1617286B1 (en) 1971-05-27
AT266126B (en) 1968-11-11
GB1147731A (en) 1969-04-02

Similar Documents

Publication Publication Date Title
AT281852B (en)
AU5917865A (en)
AU428063B2 (en)
AU415165B1 (en)
AU414526B2 (en)
AU433222B2 (en)
AU6703465A (en)
AU612166A (en)
AU5895065A (en)
BE674792A (en)
BE662818A (en)
BE692647A (en)
BE693977A (en)
BE692619A (en)
BE692542A (en)
BE694010A (en)
BE692141A (en)
AU414093B2 (en)
BE688399A (en)
BE675139A (en)
BE675084A (en)
BE674987A (en)
BE674882A (en)
BE692841A (en)
BE674777A (en)

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: ASTRA

V4 Lapsed because of reaching the maxim lifetime of a patent